Literature DB >> 6198100

T helper cell lines that augment in vivo cytotoxic T-cell responses to minor alloantigens.

N R Gascoigne, P K Lai.   

Abstract

We have investigated the ability of long-term cultured T helper (Th) cell lines to help an in vivo cytotoxic T lymphocyte (CTL) response to non-H-2 alloantigens (minor antigens). Th cell lines specific for various single or undefined minor antigens were selected by regular restimulation with antigen in vitro. They were antigen specific and H-2 restricted in proliferation assays and were found to be able to help primary CTL responses to multiple minor antigens and secondary CTL responses to single minor antigens. Although the Th were antigen specific they did not determine the specificity of the CTL. Th cells were both necessary and limiting for an effective CTL response indicating that "helper-independent" CTL are not in themselves sufficient to generate a strong in vivo response. Under conditions where a CTL response was clearly H-2 restricted, Th cells were not. Thus, the Th cells appeared to be activated by reprocessed antigen rather than antigen on the surface of the injected antigenic cells even though the CTL themselves reacted directly to the injected antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198100     DOI: 10.1016/0008-8749(84)90309-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Differential expression of the repertoire in in vitro and in vivo responses to minor alloantigens.

Authors:  N R Gascoigne; I N Crispe
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

2.  Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization.

Authors:  Yoshio Hashimoto; Horng-Shen Chen; Cynthia Cunningham; Tahir H Malik; Patrick K Lai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.